Medscape

IL-6 Vaccine Shows Early Benefit in Knee Osteoarthritis

The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.
Nasdaq

G1 Therapeutics Initiates Randomized Double Blind Placebo Controlled Phase 2 Study of COSELA™ (trilaciclib) in Non-Small Cell Lung Cancer (PRESERVE 4)

PRESERVE 4 Will Evaluate the Survival and Myeloprotection Benefits of COSELA in 146 Patients with Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Checkpoint Inhibitors RESEARCH TRIANGLE ...
Business Wire

Stimwave Announces Completion of Enrollment of the Tsunami Placebo-Controlled Double-Blind Randomized Clinical Study of Wireless DRG Stimulation for Chronic Back Pain

POMPANO BEACH, Fla.--(BUSINESS WIRE)--Stimwave Technologies, the leading innovator of wireless medical device bioelectronic technology, today announced completion of patient enrollment and preliminary ...
Earth.com

Simple daily supplement is shown to slow colorectal cancer in new study

A daily magnesium supplement alters the bacteria that produce vitamin D in the colon and could influence colorectal cancer ...
Nasdaq

Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical ...

Study met Primary and Secondary Endpoints for Safety and Regulatory T cell (Treg) Cell Population Enhancement, respectively, with no off-target effects on T effector lymphocytes, providing further ...